SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-057277
Filing Date
2021-11-16
Accepted
2021-11-16 16:00:32
Documents
15
Period of Report
2021-11-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grph-8k_20211110.htm   iXBRL 8-K 39403
2 EX-10.1 grph-ex10_10.htm EX-10 122805
3 GRAPHIC g4fcj3cw00pp000001.jpg GRAPHIC 403540
4 GRAPHIC g4fcj3cw00pp000002.jpg GRAPHIC 180501
  Complete submission text file 0001564590-21-057277.txt   1120686

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA grph-20211110.xsd EX-101.SCH 5681
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20211110_lab.xml EX-101.LAB 20256
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20211110_pre.xml EX-101.PRE 11935
8 EXTRACTED XBRL INSTANCE DOCUMENT grph-8k_20211110_htm.xml XML 3652
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 211415981
SIC: 2836 Biological Products, (No Diagnostic Substances)